Skip to main content

Table 3 CO-verified smoking cessation outcomes

From: Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation

Outcome Snus, n = 158 (%) Placebo, n = 161 (%) Odds ratio
(snus vs placebo)
95% C.I. P
Point-prevalence cessation (1 week):
-week 12 2 (1.3) 0 - - -
-week 24 9 (5.7) 3 (1.9) 3.4 0.9-12.8 0.08
-week 36 15 (9.5) 6 (3.7) 2.7 1.0-7.3 0.04
-week 48 25 (15.8) 15 (9.3) 1.9 0.9-3.7 0.08
Continued cessation at week 36:
-4 weeks 13 (8.2) 6 (3.7) 2.3 0.9-6.4 0.10
-12 weeks 9 (5.7) 3 (1.9) 3.3 0.9-12.5 0.08
-24 weeks 2 (1.3) 0 - - -
Continued cessation at week 48:
-4 weeks 22 (13.9) 12 (7.5) 2.1 1.0-4.4 0.06
-12 weeks 15 (9.5) 6 (3.7) 2.7 1.0-7.3 0.04
-24 weeks 9 (5.7) 3 (1.9) 3.3 0.9-12.5 0.08